[Practical aspects of COVID-19 autopsies]. 2021

Peter Boor, and Philip Eichhorn, and Arndt Hartmann, and Sigurd F Lax, and Bruno Märkl, and Thomas Menter, and Kristijan Skok, and Julia Slotta-Huspenina, and Saskia von Stillfried, and Alexandar Tzankov, and Gregor Weirich
Institut für Pathologie, Universitätsklinikum Aachen, RTWH Aachen, Aachen, Deutschland.

BACKGROUND The COVID-19 pandemic represents a so far unknown challenge for the medical community. Autopsies are important for studying this disease, but their safety was challenged at the beginning of the pandemic. OBJECTIVE To determine whether COVID-19 autopsies can be performed under existing legal conditions and which safety standards are required. METHODS The autopsy procedure undertaken in five institutions in Germany, Austria, and Switzerland is detailed with respect to legal and safety standards. RESULTS In all institutions the autopsies were performed in technically feasible rooms. The personal equipment consisted of functional clothing including a disposable gown and apron, a surgical cap, eye protection, FFP‑3 masks, and two pairs of gloves. In four institutions, complete autopsies were performed; in one institution the ultrasound-guided biopsy within the postmortal imaging and biopsy program. The latter does not allow the appreciation of gross organ pathology; however, it is able to retrieve standardized biopsies for diagnostic and research purposes. Several scientific articles in highly ranked journals resulted from these autopsies and allowed deep insights into organ damage and conclusions to better understand the pathomechanisms. Viral RNA was frequently detectable in the COVID-19 deceased, but the issue of infectivity remains unresolved and it is questionable if Ct values are greater than 30. CONCLUSIONS With appropriate safeguards, autopsies of people who have died from COVID-19 can be performed safely and are highly relevant to medical research.

UI MeSH Term Description Entries
D005858 Germany A country in central Europe, bordering the Baltic Sea and the North Sea, between the Netherlands and Poland, south of Denmark. The capital is Berlin.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D001317 Austria A country located in Central Europe, north of Italy and Slovenia. The capital is Vienna.
D001344 Autopsy Postmortem examination of the body. Autopsies,Post-Mortem Examination,Postmortem Examination,Examination, Post-Mortem,Examination, Postmortem,Examinations, Post-Mortem,Examinations, Postmortem,Post Mortem Examination,Post-Mortem Examinations,Postmortem Examinations
D013557 Switzerland A country in Europe. It is bordered by Austria, France, Italy, Liechtenstein, and Germany. The capital is Bern.
D058873 Pandemics Epidemics of infectious disease that have spread to many countries, often more than one continent, and usually affecting a large number of people. Pandemic

Related Publications

Peter Boor, and Philip Eichhorn, and Arndt Hartmann, and Sigurd F Lax, and Bruno Märkl, and Thomas Menter, and Kristijan Skok, and Julia Slotta-Huspenina, and Saskia von Stillfried, and Alexandar Tzankov, and Gregor Weirich
April 2022, Irish journal of medical science,
Peter Boor, and Philip Eichhorn, and Arndt Hartmann, and Sigurd F Lax, and Bruno Märkl, and Thomas Menter, and Kristijan Skok, and Julia Slotta-Huspenina, and Saskia von Stillfried, and Alexandar Tzankov, and Gregor Weirich
May 2020, American journal of clinical pathology,
Peter Boor, and Philip Eichhorn, and Arndt Hartmann, and Sigurd F Lax, and Bruno Märkl, and Thomas Menter, and Kristijan Skok, and Julia Slotta-Huspenina, and Saskia von Stillfried, and Alexandar Tzankov, and Gregor Weirich
November 2020, Legal medicine (Tokyo, Japan),
Peter Boor, and Philip Eichhorn, and Arndt Hartmann, and Sigurd F Lax, and Bruno Märkl, and Thomas Menter, and Kristijan Skok, and Julia Slotta-Huspenina, and Saskia von Stillfried, and Alexandar Tzankov, and Gregor Weirich
July 2020, Autopsy & case reports,
Peter Boor, and Philip Eichhorn, and Arndt Hartmann, and Sigurd F Lax, and Bruno Märkl, and Thomas Menter, and Kristijan Skok, and Julia Slotta-Huspenina, and Saskia von Stillfried, and Alexandar Tzankov, and Gregor Weirich
June 2022, Medicina intensiva,
Peter Boor, and Philip Eichhorn, and Arndt Hartmann, and Sigurd F Lax, and Bruno Märkl, and Thomas Menter, and Kristijan Skok, and Julia Slotta-Huspenina, and Saskia von Stillfried, and Alexandar Tzankov, and Gregor Weirich
June 2022, Medicina intensiva,
Peter Boor, and Philip Eichhorn, and Arndt Hartmann, and Sigurd F Lax, and Bruno Märkl, and Thomas Menter, and Kristijan Skok, and Julia Slotta-Huspenina, and Saskia von Stillfried, and Alexandar Tzankov, and Gregor Weirich
October 2020, Cleveland Clinic journal of medicine,
Peter Boor, and Philip Eichhorn, and Arndt Hartmann, and Sigurd F Lax, and Bruno Märkl, and Thomas Menter, and Kristijan Skok, and Julia Slotta-Huspenina, and Saskia von Stillfried, and Alexandar Tzankov, and Gregor Weirich
October 2020, Archives of pathology & laboratory medicine,
Peter Boor, and Philip Eichhorn, and Arndt Hartmann, and Sigurd F Lax, and Bruno Märkl, and Thomas Menter, and Kristijan Skok, and Julia Slotta-Huspenina, and Saskia von Stillfried, and Alexandar Tzankov, and Gregor Weirich
November 2023, Nature microbiology,
Peter Boor, and Philip Eichhorn, and Arndt Hartmann, and Sigurd F Lax, and Bruno Märkl, and Thomas Menter, and Kristijan Skok, and Julia Slotta-Huspenina, and Saskia von Stillfried, and Alexandar Tzankov, and Gregor Weirich
March 2021, Diagnostic histopathology (Oxford, England),
Copied contents to your clipboard!